For research and education only · Not reviewed by a medical professional · Disclaimer

Peptide encyclopedia/ Oxytocin
Illustration for Oxytocin

THE PEPSRADAR ENCYCLOPEDIA

Oxytocin

Uterine contraction in obstetric care

Prescription medicines · Sources checked 2026-10-04

Read the studies ↓Explore the molecule ↗

Oxytocin · KEY FACTS

Content updated · how dates work

Saved peptides

What is Oxytocin?

Oxytocin is a peptide hormone used in supervised obstetric care. Its established clinical context should be separated from popular social or wellness claims.

Biological role or research focus

Uterine contraction in obstetric care.

Clinical obstetric uses do not establish online claims about bonding, mood, or sexual enhancement.

Role reference: MedlinePlus · Oxytocin ↗

Class / identity
Oxytocic hormone
Main research area
Obstetric care
Evidence featured
Human randomized trial
Source check
October 4, 2026

Source: MedlinePlus · Oxytocin ↗

Quick answers

Is Oxytocin FDA approved?
Yes. Pitocin (NDA 018261) and generic oxytocin injection to induce or strengthen labor and control postpartum bleeding. Source ↗
Is Oxytocin safe?
Oxytocin (Pitocin) is a hospital-only labor drug; too much can overstimulate or rupture the uterus, cause dangerous water intoxication and harm the baby. Human safety data: its FDA label lists the known risks. The Risks & interactions section below lists what is known. Read the risks ↓
Is Oxytocin banned in sport?
It is not named on the 2026 World Anti-Doping Agency (WADA) Prohibited List. Athletes should still check with their sport’s anti-doping body. Source ↗

What does the evidence show?

Evidence map

Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.

2 Human research
StudyTypePopulation / model
Route comparison after vaginal birth (2018)Human randomized trial1,075 women randomized; 1,035 included in analyses at an Irish maternity unit.
SOARS-B · intranasal oxytocin (2021)Human phase 2 randomized trial290 participants aged 3–17; 277 contributed to the modified intention-to-treat analysis.

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Human randomized trial · 2018

Route comparison after vaginal birth

Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial.

Population / model
1,075 women randomized; 1,035 included in analyses at an Irish maternity unit.
Study design
Intravenous versus intramuscular oxytocin with matching placebo injections.
Main finding
The primary bleeding endpoint was not significantly different. Severe postpartum bleeding, a secondary endpoint, occurred in 4.6% versus 8.1%, favoring intravenous administration.
Limits & context
Both groups received oxytocin under clinical supervision. This addresses route selection after delivery, not bonding, mood, or unsupervised nasal-spray use.

Source: Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial. ↗

Human phase 2 randomized trial · 2021

SOARS-B · intranasal oxytocin

Did social functioning improve in children and adolescents with autism?

Population / model
290 participants aged 3–17; 277 contributed to the modified intention-to-treat analysis.
Study design
24-week placebo-controlled intranasal trial, stratified by age and verbal fluency.
Main finding
The primary social-withdrawal score changed by −3.7 versus −3.5 points; difference −0.2 (95% CI −1.5 to 1.0), P=0.61. Secondary outcomes generally did not differ. Adverse-event frequency and severity were similar.
How to read it
The larger trial did not show benefit on its measured social or cognitive outcomes.
Limits & context
These results concern the studied population, formulation, and duration. They do not establish a general bonding or cognitive-enhancement effect, nor determine outcomes in every other clinical setting.

Source: SOARS-B · intranasal oxytocin · 2021 ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Registered human trials

67 registered studies name Oxytocin as an intervention among the 100 most recently updated of 938 search results; 34 are recruiting or under way, 12 have not started recruiting yet, 15 completed and 6 ended early, were withdrawn or have another status. Checked November 16, 2026 on ClinicalTrials.gov.

StudyStatusPhaseStartPeople
Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium
NCT06930391 · Samuel Lunenfeld Research Institute, Mount Sinai Hospital
RecruitingNot applicable2025-09-1540
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
NCT07409753 · Wake Forest University Health Sciences
RecruitingPhase 22025-10-2260
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
NCT05664516 · Massachusetts General Hospital
Active, not recruitingPhase 22023-03-0760
Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk
NCT06713473 · Florida State University
WithdrawnNot applicable2026-080
Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery
NCT07730294 · Yale University
RecruitingPhase 22026-1175
The Effects of Hypnobreastfeeding and Oxytocin Massage on Breastfeeding
NCT07921485 · Sümeyye ALTIPARMAK
CompletedNot applicable2020-09-01270
Comparison of Effect of Two Different Doses of Intravenous Oxytocin on Patients Undergoing Elective Cesarean Section
NCT07922083 · Shalamar Hospital
Not yet recruitingNot applicable2026-12-01120
Inducing Self-Dehumanization to Examine Oxytocin and Suicide Risk
NCT06710964 · Florida State University
WithdrawnNot applicable2026-100

A registration shows a study was planned; it is not a result. Some studies use the compound only as a comparison or in a combination. All 67 listed studies.

Search additional PubMed records ↗

Risks & interactions

Oxytocin (Pitocin) is a hospital-only labor drug; too much can overstimulate or rupture the uterus, cause dangerous water intoxication and harm the baby.

FDA boxed warning

Not approved for elective induction of labor (starting labor without a medical reason), because the available data are not enough to weigh the benefits against the risks.

Human safety data: FDA label

Safety is established by FDA labeling and long hospital use in labor and after delivery. The label lists reactions without frequencies, and states that data are inadequate to judge elective induction. It is given only under hospital supervision.

Take extra care with: Heart or blood pressure problemsPregnancy or breastfeeding

From the FDA label lists below. If a condition applies to you, talk to a doctor or pharmacist first. Each tag opens every profile that mentions it.

Who should not use it

  • Baby cannot safely pass through the pelvis, or is in a position that cannot be delivered
  • Fetal distress when delivery is not about to happen
  • Uterus already overactive or contracting too strongly
  • When vaginal delivery is unsafe, such as placenta previa, cord prolapse or active genital herpes
  • Obstetric emergencies that favor surgical delivery
  • Allergy to oxytocin

Interactions

  • Vasoconstrictors given with caudal block anesthesia: severe high blood pressure has been reported
  • Cyclopropane anesthesia: can cause low blood pressure and abnormal heart rhythms in the mother

Serious risks

  • Overly strong contractions and rupture of the uterus
  • Water intoxication with seizures, coma or death
  • Heavy bleeding after delivery and fatal loss of clotting protein (afibrinogenemia)
  • Severe allergic reactions
  • Irregular heartbeat and episodes of high blood pressure in the mother
  • Harm to the baby, including slow heart rate, seizures, brain damage or death

Common side effects

  • nausea
  • vomiting

Summarized from the FDA label with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: DailyMed: Pitocin (oxytocin) prescribing information ↗

Key precautions

Excessive uterine stimulation and other serious complications require monitoring by the maternity team. Prior uterine surgery, fetal position, and placental conditions can affect suitability.

Source: MedlinePlus · Oxytocin ↗

Regulatory status

U.S. FDA approval
Approved
Pitocin (NDA 018261) and generic oxytocin injection to induce or strengthen labor and control postpartum bleeding. source
FDA compounding (503A bulk list)
Not on FDA’s compounding lists
Not on FDA's 503A nominated-substance category lists. As a component of an FDA-approved drug it does not need to be on the 503A bulks list to be used in pharmacy compounding (other 503A conditions still apply). source
World Anti-Doping Agency (2026)
Not on the WADA Prohibited List
Not named and not within a prohibited class on the 2026 List. source

Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

Clinical uses & product context

The medication reference describes initiating or strengthening labor contractions and reducing bleeding after childbirth. Clinical circumstances, fetal status, and obstetric contraindications guide its use.

Source: MedlinePlus · Oxytocin ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Sources & supplier listings

Why there are no prices here

This is a prescription medicine, available only with a prescription through a pharmacy. Versions sold online as "research" products are not the approved medicine, and the FDA has warned sellers of them, so PepsRadar does not list, compare or link them. See the official product information linked in References.

Mechanism & research rationale

It stimulates uterine contractions. That action explains labor-related and postpartum uses but does not establish a predictable improvement in bonding or mood.

Source: MedlinePlus · Oxytocin ↗

Molecular structure

Oxytocin: 2d molecular structure. The cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.⤢ Enlarge 2D
2D molecular structureThe cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.PubChem · CID 439302 ↗

Questions worth asking

  • Which indication and formulation does the source describe?
  • Does the video make a broader claim than the source supports?
  • Clinical obstetric uses do not establish online claims about bonding, mood, or sexual enhancement.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Video & podcast discussions: members library

Frequently asked questions

Does an obstetric trial validate a bonding nasal spray?

No. Route, population, and outcome all differ.

Source: MedlinePlus · Oxytocin ↗

Did the route-comparison study show every bleeding outcome improved?

No. The primary endpoint was not significantly different; some secondary outcomes favored intravenous administration.

Source: Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial. ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

See something wrong on this page? Report a mistake · Corrections

MOLECULAR ATLAS

Oxytocin

Download illustration ↓Source record ↗
Oxytocin 2d molecular structure

The cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.